Biodistribution and toxicity of MR imaging contrast media.
Oksendal
A N
AN
Nycomed Imaging AS, Oslo, Norway.
Hals
P A
PA
D000818:Animals; D001853:Bone Marrow / Q000033:anatomy & histology; D003287:Contrast Media / Q000009:adverse effects*; D003911:Dextrans; D004064:Digestive System / Q000033:anatomy & histology; D004419:Dysprosium / Q000009:adverse effects; D052203:Ferrosoferric Oxide; D005682:Gadolinium / Q000009:adverse effects; D006801:Humans; D007501:Iron / Q000009:adverse effects; D008099:Liver / Q000033:anatomy & histology; D008198:Lymph Nodes / Q000033:anatomy & histology; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D012157:Mononuclear Phagocyte System / Q000033:anatomy & histology; D010087:Oxides / Q000009:adverse effects; D013154:Spleen / Q000033:anatomy & histology; D014018:Tissue Distribution
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; D004419:Dysprosium; D005682:Gadolinium; D007501:Iron; C065507:ferumoxides; D052203:Ferrosoferric Oxide